Pharmafile Logo
Pharmafocus logo
Advanced Search

Particle Works partners with Earli Inc. to develop DNA-LNPs for early-stage cancer treatment

March 27, 2023
Business Services

Particle Works, a leading provider of innovative microfluidic nanoparticle synthesis platforms, is supporting Earli Inc. in its mission to detect, …

News
Press release

Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease

March 27, 2023
Business Services

NEW ORLEANS, LA and CAMBRIDGE, England, March 27, 2023 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing …

News
Press release

Statement Following Jounce Therapeutics Announcement of a Definitive Merger Agreement with Concentra Biosciences and Withdrawal of their Recommendation for the Business Combination with Redx

March 27, 2023
Business Services

Alderley Park, UK 27 March 2023 Redx Pharma (“Redx”, AIM: REDX), the clinical-stage biotechnology company focused on discovering and developing …

News
Press release

MHRA Grants Conditional Marketing Authorisation in Great Britain to CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Haemophilia B

March 27, 2023
Business Services

This medicine is subject to additional monitoring.This will allow quick identification of new safety information.

News
Press release

Avacta to present pre-clinical data on AVA3996 at the American Association for Cancer Research Annual Meeting

March 27, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces it will …

News
Press release

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

March 27, 2023
Business Services

Leiden, The Netherlands, March 24, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the …

News
Press release

Novartis announces positive results from phase 3 trial of Kisqali for early breast cancer

March 27, 2023
Research and Development

Novartis has announced positive results from its phase 3 NATALEE trial assessing Kisqali (ribociclib) along with endocrine therapy (ET) in …

News

Abberior installs new STED microscope at MBC BioLabs

March 27, 2023
Medical Communications

Abberior has announced that it has placed a super-resolution STED microscope at MBC BioLabs, which is the leading San Francisco …

News

FDA releases draft of accelerated approval guidance for oncology therapeutics

March 27, 2023
Medical Communications

The FDA has released a draft of new guidance for accelerated approval for oncology therapeutics, highlighting the need for stricter …

News

University of Leipzig and SiSaf partner over Bio-Courier targeted miRNA

March 27, 2023
Medical Communications

SiSaf, an RNA delivery and therapeutics company, has announced a collaboration with the University of Leipzig to develop Bio-Courier targeted …

News

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

March 24, 2023
Business Services

NEW YORK and BERLIN, March 24, 2023 (GLOBE NEWSWIRE) — atai Life Sciences&

News
Press release

Announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology Demonstrates significant reduction of nasal S. aureus in preoperative cardiac surgery patients

March 24, 2023
Business Services

Brighton, United Kingdom – 24 March 2023 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the …

News
Press release

NICE recommends PTC Therapeutics’ gene therapy for NHS use

March 24, 2023
Medical Communications

NICE has recommended PTC Therapeutics’ gene therapy to the NHS for the treatment of ultra-rare disease aromatic L-amino acid decarboxylase …

News

Creative Medical Technology files FDA ODD application for Brittle Type 1 diabetes

March 24, 2023
Medical Communications

US-based biotech company Creative Medical Technology has announced that it has filed for the FDA’s Orphan Drug Designation (ODD) for …

News

European Commission delays release of major changes to pharma legislation

March 24, 2023
Medical Communications

The European Commission (EC) has again delayed the release of its new proposal for changes to Europe’s pharma legislation. The …

News

NeuroRPM announces FDA clearance for AI monitoring app for Parkinson’s disease on Apple Watch

March 24, 2023
Medical Communications

NeuroRPM has announced that it has received clearance from the FDA for its NeuroRPM device which uses AI and existing …

News

NICE publishes guidance recommending Bayer’s Kerendia® (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes

March 23, 2023
Business Services

Reading, 23rd March 2023 – Today, the National Institute for Health and Care Excellence (NICE) has published a new guidance …

News
Press release

SYMBICORT (budesonide/formoterol) TURBOHALER 200/6 APPROVED AS FIRST AND ONLY COMBINATION RELIEVER FOR MILD ASTHMA IN THE UK

March 23, 2023
Business Services

London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …

News
Press release

BIAL appoints Max Bricchi as Chief Commercial Officer

March 23, 2023
Business Services

BIAL has announced the appointment of Max Bricchi as Chief Commercial Officer (CCO) and Executive Board member. With responsibility for …

Appointment

Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting

March 23, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 23 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026